Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Conditions
Resectable Intrahepatic Cholangiocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
Contact: Principal Investigator (Zeljka Jutric)Los Angeles General Medical Center, Los Angeles, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Contact: Principal Investigator (Zeljka Jutric)UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Sarah L. Davis)Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Yale University, New Haven, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States
Contact: Principal Investigator (Ali Zarrinpar)Emory University Hospital Midtown, Atlanta, Georgia, United States
Contact: Principal Investigator (Seth Concors)Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Seth Concors)Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Seth Concors)Northwestern University, Chicago, Illinois, United States
Contact: Principal Investigator (Aparna Kalyan)Memorial Hospital East, Shiloh, Illinois, United States
Contact: Principal Investigator (Olivia Aranha)University of Kansas Clinical Research Center, Fairway, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States
Contact: Principal Investigator (Jonathan D. Mizrahi)University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Daniel Shu)Boston Medical Center, Boston, Massachusetts, United States
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center - North, Kansas City, Missouri, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
Contact: Principal Investigator (Raed Al-Rajabi)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)NYP/Weill Cornell Medical Center, New York, New York, United States
Contact: Principal Investigator (Rutika Mehta)Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Michael McCormack)University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Davendra P. Sohal)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Jordan M. Cloyd)University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States
Contact: Principal Investigator (Davendra P. Sohal)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Hassan Hatoum)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Anwaar Saeed)Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island, United States
Contact: Principal Investigator (Raghav Sundar)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Thatcher R. Heumann)UT MD Anderson - The Woodlands, Conroe, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)UT MD Anderson - West Houston, Houston, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)UT MD Anderson - League City, League City, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
UT MD Anderson - Sugar Land, Sugar Land, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Glynn W. Gilcrease)University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303Contact: Principal Investigator (Matthew J. Reilley)VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Contact: Principal Investigator (Emily N. Kinsey)University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
Contact: Principal Investigator (Jeremy Kratz)University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Principal Investigator (Jeremy Kratz)
Study leads
Hop S Tran Cao
Principal Investigator
University of Texas MD Anderson Cancer Center LAO